Wed Oct 1 18:11:37 SGT 2014  
HEPATITIS
B
    Hepatitis B, Philippines
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Hepatitis B, Philippines

Summary

Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Anti-hepatitis B virus activities and absolute configurations of sesquiterpenoid glycosides from Phyllanthus emblica
Tue, 30 Sep 2014 23:11:12 +0100 | RSC - Organic Biomolecular Chemistry
Org. Biomol. Chem., 2014, Advance ArticleDOI: 10.1039/C4OB01196A, PaperJun-Jiang Lv, Ya-Feng Wang, Jing-Min Zhang, Shan Yu, Dong Wang, Hong-Tao Zhu, Rong-Rong Cheng, Chong-Ren Yang, Min Xu, Ying-Jun ZhangThe sesquiterpenoid glycoside dimers isolated from Phyllanthus emblica have anti-HBV activities towards HBsAg and HBeAg secretions inhibition.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Organic Biomolecular Chemistry)

Differences in Surgical Outcomes Between Hepatitis B- and Hepatitis C–Related Hepatocellular Carcinoma: A Retrospective Analysis of a Single North American Center
Tue, 30 Sep 2014 20:11:29 +0100 | Annals of Surgery
Conclusions: Survival after both resection and transplantation for HCC was better in HBV- than in HCV-related HCC whereas recurrence was also lower for HBV-HCC in the resection group, these differences are influenced by both liver and tumor factors. (Source: Annals of Surgery)

Realizing the Potential of Treatment as Prevention: Global ART Policy and Treatment Coverage
Mon, 29 Sep 2014 22:08:38 +0100 | Current HIV/AIDS Reports
This article reviews the antiretroviral therapy (ART) initiation criteria from published national guidelines for 94 countries (representing 86 % of global HIV burden) and compares them with the 2013 World Health Organization (WHO) ART guidelines. As of 31st of July 2014, 19 countries have adopted the WHO-recommended CD4 eligibility criteria of ≤500 cells/mm3, while seven have opted to treat irrespective of CD4 cell count (“test and treat”). Together, these 26 countries represent 27 % of 2013 global HIV burden. Additionally, test and treat is recommended for selected groups of HIV-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis B co-infection in 52 countries, (d) serodiscor...

Liberia: Liberian Doctor Defends 3-5 Days Ebola Treatment With HIV Drug
Mon, 29 Sep 2014 11:42:16 +0100 | AllAfrica News: Health and Medicine
[FrontPageAfrica]"When the patients come early, and they are put on this medication, they recover within three to five days. This medication is not specifically for HIV/AIDS, I want this to be clear; but the Anti Retrovirus agent that is used to treat other virus illnesses like hepatitis 'B'. But it is one of those medications that are combined with two or three other medications to treat HIV/AIDS, so it should not really be called an HIV/AIDS drugs." - Dr. G. Gorbee Logan, County Health Officer, Tubmanburg Hospital (Source: AllAfrica News: Health and Medicine)

The collagen triple helix repeat containing 1 facilitates hepatitis B virus‐associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades
Sat, 27 Sep 2014 00:00:00 +0100 | Molecular Carcinogenesis
Hepatitis B virus (HBV) infection is one of the major causes of acute and chronic liver diseases, fulminant hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). HCC accounts for more than 85% of primary liver cancers and is the seventh most common cancer and the third leading cause of cancer‐related deaths. However, the mechanism by which HBV induces HCC is largely unknown. Collagen triple helixes repeat containing 1 (CTHRC1) is a secreted protein and has characteristics of a circulating hormone with potentially broad implications for cell metabolism and physiology. CTHRC1 is associated with human cancers, but its effect on HCC is unknown. Here, we revealed that CTHRC1 expression is highly correlated with HCC progression in HBV‐infected patients, and demonstrated that HBV stimulat...

Effect of pre-analytical variables on coagulation tests in hepatitis B patients
Fri, 26 Sep 2014 11:23:06 +0100 | Blood Coagulation and Fibrinolysis
To determine the effects of various pre-analytical variables on the values of activated partial thromboplastin time (APTT), D-dimers, fibrinogen (Fbg), prothrombin time (PT) and thrombin time (TT). Samples from 120 hepatitis B patients were divided into three groups based on storage time (0–24 h), mechanical agitation and separation into plasma. In all groups, samples were stored at room temperature and 4°C. The percentage changes compared to the baseline were calculated. Clinically relevant differences were defined as a more than 10% change. If less than 25% samples showed relevant differences, the effect of the pre-analytical variable was considered moderate; if more than 25% of samples showed relevant differences, the effect was deemed large. Clinically relevant differences in APTT...

The duration of hepatitis B vaccine immunity in pediatric dialysis patients
Fri, 26 Sep 2014 00:47:57 +0100 | Pediatric Nephrology
Conclusions

Assessing Adherence to Accepted National Guidelines for Immigrant and Refugee Screening and Vaccines in an Urban Primary Care Practice: A Retrospective Chart Review
Fri, 26 Sep 2014 00:33:17 +0100 | Journal of Immigrant and Minority Health
Abstract

Knowledge and Practices of Healthcare Workers in Relation to Bloodborne Pathogens in a Tertiary Care Hospital, Western Saudi Arabia
Fri, 26 Sep 2014 00:33:11 +0100 | Journal of Community Health
Abstract

Impact of intervention on healthcare waste management practices in a tertiary care governmental hospital of Nepal
Fri, 26 Sep 2014 00:00:00 +0100 | BioMed Central
Conclusions: